Labverity
Facility profile

The Richline Group, Inc.

Drug product manufacturing · Tamarac, FL

FDA recordFDA directory updated Jul 21, 2026Profile not yet claimed
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

LabelManufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 21, 2026

Latest matched inspection
Official action indicated (OAI)

Apr 16, 2025 · The findings may warrant official FDA action.

Matched compliance actions
Warning Letter · Aug 2025

Within five years · review the action and follow-up.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched official action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Review the underlying findings, response, and subsequent follow-up before qualification.

Method and source details
View full inspection and compliance history4 inspection records

FDA inspection history

4 records, Nov 2016 – Apr 2025 · 0 NAI · 2 VAI · 2 OAI

DateClassProject areaCitationsFY
Apr 16, 2025VAIPostmarket Assurance: DevicesYes2025
Apr 16, 2025OAICompliance: DevicesYes2025
Jan 12, 2024OAICompliance: DevicesYes2024
Nov 3, 2016VAIDrug Quality AssuranceYes2017

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

Aug 25, 2025Warning Letter · CDRH
Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services